![Dennis Thiele](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dennis Thiele
Director/Miembro de la Junta en Chaperone Therapeutics, Inc. .
Perfil
Dennis Thiele currently works at Chaperone Therapeutics, Inc., as Director and Sisu Pharma, Inc., as Director.
Cargos activos de Dennis Thiele
Empresas | Cargo | Inicio |
---|---|---|
Chaperone Therapeutics, Inc.
![]() Chaperone Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Chaperone Therapeutics, Inc. develops disease-modifying therapies for neurodegenerative and rare diseases caused by protein misfolding. Its therapeutic approach elevates the natural protein folding and stress protection mechanisms to prevent protein misfolding and the ensuing cell dysfunction and death. The company is headquartered in Chapel Hill, NC | Director/Miembro de la Junta | - |
Sisu Pharma, Inc.
![]() Sisu Pharma, Inc. Pharmaceuticals: MajorHealth Technology Sisu Pharma, Inc. provides pharmaceutical services. The company is headquartered in Chapel Hill, NC. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Chaperone Therapeutics, Inc.
![]() Chaperone Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Chaperone Therapeutics, Inc. develops disease-modifying therapies for neurodegenerative and rare diseases caused by protein misfolding. Its therapeutic approach elevates the natural protein folding and stress protection mechanisms to prevent protein misfolding and the ensuing cell dysfunction and death. The company is headquartered in Chapel Hill, NC | Commercial Services |
Sisu Pharma, Inc.
![]() Sisu Pharma, Inc. Pharmaceuticals: MajorHealth Technology Sisu Pharma, Inc. provides pharmaceutical services. The company is headquartered in Chapel Hill, NC. | Health Technology |
- Bolsa de valores
- Insiders
- Dennis Thiele